Actively Recruiting
Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes
Led by Centre Hospitalier Charles Perrens, Bordeaux · Updated on 2025-12-01
200
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The perinatal period is recognized as a time of heightened psychological vulnerability. This research aims to improve the diagnosis and therapeutic management of mood episodes occurring during this time. It is integrated into routine clinical care and seeks to standardize the evaluation of criteria used to characterize mood episodes, while also exploring relevant contextual factors. Traditionally, clinical attention has focused on postnatal depression; however, increasing evidence highlights the presence of hypomanic symptoms-such as distractibility, reduced need for sleep, tachypsychia, and irritability-during the postpartum period. These symptoms may coexist with depressive features, resulting in complex clinical presentations that are often difficult to recognize and manage. Consequently, many cases go undiagnosed and untreated. Current research has largely concentrated on depressive episodes (perinatal depression), with less emphasis on manic, hypomanic, or mixed episodes indicative of bipolar disorder. A systematic evaluation of hypomanic symptoms occurring alongside depressive symptoms in the postpartum period could refine clinical diagnosis and support more targeted and effective therapeutic interventions.
CONDITIONS
Official Title
Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women over 18 years old
- Pregnant or having given birth less than a year ago
- First psychiatric consultation for the pregnancy concerned
- Good command of the French language
- Participant affiliated to the social security system
- Participant who has given her consent to take part in the study
You will not qualify if you...
- Women who gave birth more than a year ago
- Participant under psychiatric care
- Participant under court protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier CHARLES PERRENS
Bordeaux, New Aquitaine, France, 33076
Actively Recruiting
Research Team
A
Anne-Laure SUTTER DALLAY, Prof, MD, PhD
CONTACT
H
Helen SAVARIEAU
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here